Class IITerminatedD-0840-2020
Drug recall · February 19, 2020
Kushim Tablets recall
Why: Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Kushim Tablets (Gushim) 45-count packages, Label in foreign language
- Lots / codes
Lot #: H003
- Quantity
- 40 packages
- Company
- B And A Trading Corporation, Carlstadt, NJ
- Distribution
- NY & NJ only
- Initiated
- January 28, 2020 · Voluntary: Firm initiated
- Classified
- February 12, 2020
- Reported
- February 19, 2020
- Ended
- December 21, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.